Nature Communications (Oct 2018)

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition

  • Julien Robert-Paganin,
  • Daniel Auguin,
  • Anne Houdusse

DOI
https://doi.org/10.1038/s41467-018-06191-4
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 13

Abstract

Read online

Hypertrophic cardiomyopathy (HCM) is caused by point mutations in sarcomeric proteins. Here the authors develop an optimized model of the sequestered state of cardiac myosin and define the features affecting the lever arm compliance, allowing them to group mutations in classes and to elucidate the molecular mechanisms leading to cardiac dysfunction in HCM.